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Summary. In the present retrospective study, liver cell 
dysplasia (LCD) occurring in cirrhotic livers associated 
or not associated with hepatocellular carcinoma (HCC) 
was immunohistochemically analyzed for the expression 
of hepatocyte growth factor receptor (c-met protein), Rb 
(retinoblastoma gene) protein, E-cadherin, and trans- 
forming growth factor-B-l (TGF-B-1). Cytoplasmic c- 
met protein staining was observed in about half of the 
HCC's, and its prevalence was about twice as high in 
high grade vs. low grade tumors, but it was not 
correlated with proliferative activity as based on PCNA 
labelling. In LCD, reactivity for c-met protein was 
restricted to the small cell type. Nuclear staining for Rb 
protein was found in HCC's, and was not related to type, 
grade or proliferative activity, whereas no immuno- 
reactivity was observed in normal, hyperplastic or 
dysplastic hepatocytes. Expression of E-cadherin 
prevailed in HCC's of lower grade, and particularly in 
those with a trabecular or acinar growth pattern. E- 
cadherin staining was detectable in normal and large 
dysplastic hepatocytes, but not in small dysplastic liver 
cells. TGF-B-1 reactivity was observed in more than half 
the HCC's, but not in normal or dysplastic hepatocytes. 
These findings underline the phenotypic difference 
between large cell and small cell liver dysplasia, and 
support the hypothesis that small cell dysplasia is a 
precursor lesion in a hepatocarcinogenic pathway. 
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Introduction 
As hepatocellular carcinoma (HCC) is, on a world- 
wide scale, one of the most important solid tumors, i t  is 
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of particular interest to study its precursor lesions. 
Whereas pathways involved in liver carcinogenesis in 
laboratory animals have been investigated in detail, 
knowledge relating to hepatic preneoplastic changes in 
humans is still incomplete. Probable precursors include 
liver cell dysplasia (LCD; Anthony, 1976; Serov and 
Beketova, 1990) and nodular lesions comprising atypical 
adenomatous hyperplasia, macroregenerative nodules 
with bulging activity and nodule-in-nodule lesions (for 
reviews, see Nakanuma et al., 1990; Okuda, 1992). LCD 
was originally detected in the liver of HBsAg-positive 
Ugandan patients and was suggested to represent a 
preneoplastic change (Anthony, 1976), but this hypo- 
thesis has been discussed in the following years, 
sometimes with a controversial outcome (Akagi et al., 
1984; Roncalli et al., 1985; Chopra et al., 1987; Kovacs 
and Elek, 1987; Lefkowitch and Apfelbaum, 1987; Reid 
et al., 1987; Matturri and Bauer, 1988; Watanabe et al., 
1988; Borzio et al., 1991; Hytiroglou et al., 1992). For 
Western countries, the etiology of liver cirrhosis has not 
been conclusively demonstrated to be of relevance for 
the presence of LCD (Theise et al., 1992), even though 
LCD is relatively frequently encountered in hepatitis C 
virus infection (Ferrel et al., 1992). Several studies 
support the view that dysplastic hepatocytes form a liver 
cell population subject to probable neoplastic evolution, 
based on immunohistochemical (Roncalli et al., 1985, 
1986; Govindarajan et al. ,  1990),  morphometric 
(Giannini et al., 1987; Roncalli et al., 1988; Zhao et al, 
1994a) and DNA ploidy (Zerbini et al., 1992) findings. 
Recently, we could show that the prevalence of LCD 
was higher in cirrhotic livers carrying HCC than in those 
without, and that karyometric features of large cell LCD 
are most close to those of highly differentiated HCC's, 
whereas karyometric features of small cell LCD closely 
reflect those of poorly differentiated HCC's (Zhao et al., 
1994a). Moreover, reactivity for p53 protein, the product 
of a tumor suppressor gene frequently mutated in HCC, 
has been detected in LCD, but in the small cell variant 
only (Zhao et a l . ,  1994b), whereas the apoptosis 
protector, bcl-2 protein, expressed in a subset of HCC's, 
was not detectable in LCD (Zhao et al., 1 9 9 4 ~ ) .  It 













